AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa

Kawata,Soichiro; Yashima,Kazuo; Yamamoto,Sohei; Sasaki,Shuji; Takeda,Yohei; Hayashi,Akihiro; Matsumoto,Kazuya; Kawaguchi,Koichiro; Harada,Kenichi; Murawaki,Yoshikazu

doi:10.3892/ol.2015.3342

AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa

Authors:
- Soichiro Kawata
- Kazuo Yashima
- Sohei Yamamoto
- Shuji Sasaki
- Yohei Takeda
- Akihiro Hayashi
- Kazuya Matsumoto
- Koichiro Kawaguchi
- Kenichi Harada
- Yoshikazu Murawaki
View Affiliations

Affiliations: Division of Medicine and Clinical Science, Faculty of Medicine, Tottori University, Nishicho, Yonago 683‑8504, Japan
Published online on: June 9, 2015 https://doi.org/10.3892/ol.2015.3342
Pages: 737-743
Copyright: © Kawata et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A number of tumor-associated genes have been associated with gastric cancer development. The present study evaluated differences in tumor‑associated protein expression and phenotype among early gastric neoplasms, and correlated these data with those of the background mucosa. The expression of activation‑induced cytidine deaminase (AID), p53 and MLH1 in 151 early gastric neoplasms [22 gastric adenomas, 92 intramucosal carcinomas (MCs), and 37 submucosal carcinomas (SMCs)] was examined immunohistochemically and compared with that of the corresponding background mucosal condition. The cellular phenotypes of the neoplasms and the corresponding background intestinal metaplasia were also determined. Aberrant AID, p53 and MLH1 expression was detected in 36.4, 0 and 0% of the adenomas, in 35.9, 32.6 and 16.3% of the MCs, and in 56.8, 62.2 and 21.6% of the SMCs, respectively. The frequency of aberrant AID and p53 expression in the SMCs was significantly increased compared with that in the MCs (AID, P<0.05; p53, P<0.01). Aberrant AID expression was significantly associated with p53 overexpression in the SMCs (P<0.01), but not in the adenomas or MCs. In addition, AID expression was associated with the severity of mononuclear cell activity in the non‑cancerous mucosa adjacent to the tumor (P<0.05), particularly in the SMC cases. The percentage of MCs (34.8%) and SMCs (24.3%) that were of the gastric phenotype was higher compared with the percentage of adenomas (18.2%). These results indicated that p53 and MLH1 expression and a gastric phenotype may be important for carcinogenesis, and that chronic inflammation and AID and p53 expression are associated with submucosal progression.

View Figures

View References

1	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
2	Correa P: Human gastric carcinogenesis: A multistep and multifactorial process - First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 52:6735–6740. 1992.PubMed/NCBI
3	Uemura N, Okamoto S, Yamamoto S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 345:784–789. 2001. View Article : Google Scholar : PubMed/NCBI
4	Sipponen P and Kimura K: Intestinal metaplasia, atrophic gastritis and stomach cancer: Trends over time. Eur J Gastroenterol Hepatol. 6:(Suppl 1). S79–S83. 1994.PubMed/NCBI
5	Tamura G: Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol. 12:192–198. 2006.PubMed/NCBI
6	Yamazaki K, Tajima Y, Makino R, et al: Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol. 12:3803–3809. 2006.PubMed/NCBI
7	Hong SH, Kim HG, Chung WB, et al: DNA hypermethylation of tumor-related genes in gastric carcinoma. J Korean Med Sci. 20:236–241. 2005. View Article : Google Scholar : PubMed/NCBI
8	Fleisher AS, Esteller M, Wang S, et al: Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 59:1090–1095. 1999.PubMed/NCBI
9	Chiba T, Marusawa H and Ushijima T: Inflammation-associated cancer development in digestive organs: Mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 143:550–563. 2012. View Article : Google Scholar : PubMed/NCBI
10	Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y and Honjo T: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553–563. 2000. View Article : Google Scholar : PubMed/NCBI
11	Okazaki IM, Hiai H, Kakazu N, et al: Constitutive expression of AID leads to tumorigenesis. J Exp Med. 197:1173–1181. 2003. View Article : Google Scholar : PubMed/NCBI
12	Matsumoto Y, Marusawa H, Kinoshita K, et al: Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 13:470–476. 2007. View Article : Google Scholar : PubMed/NCBI
13	Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
14	Nakamura K, Sugano H and Takagi K: Carcinoma of the stomach in incipient phase: Its histogenesis and histological appearance. Gan. 59:251–258. 1968.PubMed/NCBI
15	Egashira Y, Shimoda T and Ikegami M: Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int. 49:55–61. 1999. View Article : Google Scholar : PubMed/NCBI
16	Yoshino T, Shimoda T, Saito A, et al: Macroscopic features of differentiated adenocarcinoma with gastric or intestinal phenotype expression in early gastric cancer. Stomach Intestine. 34:513–525. 1999.
17	Koseki K, Takizawa T, Koike M, Ito M, Nihei Z and Sugihara K: Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 89:724–732. 2000. View Article : Google Scholar : PubMed/NCBI
18	Japanese Gastric Cancer Association, . Japanese Classification of Gastric Carcinoma. 13th. Kanehara & Co., Ltd.; Tokyo: 1998, (In Japanese).
19	Schlemper RJ, Riddell RH, Kato Y, et al: The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 47:251–255. 2000. View Article : Google Scholar : PubMed/NCBI
20	Dixon MF, Genta RM, Yardley JH and Correa P: Classification and grading of gastritis The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 20:1161–1181. 1996. View Article : Google Scholar : PubMed/NCBI
21	Andachi H, Yashima K, Koda M, et al: Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma. Br J Cancer. 87:441–445. 2002. View Article : Google Scholar : PubMed/NCBI
22	Baek MJ, Kang H, Kim SE, et al: Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. Br J Cancer. 85:1147–1152. 2001. View Article : Google Scholar : PubMed/NCBI
23	Niwa T, Ikehara Y, Nakanishi H, et al: Mixed gastric- and intestinal-type metaplasia is formed by cells with dual intestinal and gastric differentiation. J Histochem Cytochem. 53:75–85. 2005. View Article : Google Scholar : PubMed/NCBI
24	Morisawa T, Marusawa H, Ueda Y, et al: Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int J Cancer. 123:2735–2740. 2008. View Article : Google Scholar : PubMed/NCBI
25	Kim CJ, Song JH, Cho YG, et al: Activation-induced cytidine deaminase expression in gastric cancer. Tumour Biol. 28:333–339. 2007. View Article : Google Scholar : PubMed/NCBI
26	Takeda Y, Yashima K, Hayashi A, et al: Expression of AID, P53 and Mlh1 proteins in endoscopically resected differentiated-type early gastric cancer. World J Gastrointest Oncol. 4:131–137. 2012. View Article : Google Scholar : PubMed/NCBI
27	Goto A, Hirahashi M, Osada M, et al: Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer. Virchows Arch. 458:717–724. 2011. View Article : Google Scholar : PubMed/NCBI
28	Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS and Hainaut P: Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 21:7435–7451. 2002. View Article : Google Scholar : PubMed/NCBI
29	Saeki H, Ohno S, Miyazaki M, et al: p53 protein accumulation in multiple oesophageal squamous cell carcinoma: Relationship to risk factors. Oncology. 62:175–179. 2002. View Article : Google Scholar : PubMed/NCBI
30	Kozack R, Seo KY, Jelinsky SA and Loechler EL: Toward an understanding of the role of DNA adduct conformation in defining mutagenic mechanism based on studies of the major adduct (formed at N(2)-dG) of the potent environmental carcinogen, benzo[a]pyrene. Mutat Res. 450:41–59. 2000. View Article : Google Scholar : PubMed/NCBI
31	Viala J, Chaput C, Boneca IG, et al: Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 5:1166–1174. 2004. View Article : Google Scholar : PubMed/NCBI
32	Endo Y, Marusawa H, Kou T, et al: Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology. 135:889–898. 898.e1–898e.3. 2008. View Article : Google Scholar : PubMed/NCBI
33	Endo Y, Marusawa H, Kinoshita K, et al: Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene. 26:5587–5595. 2007. View Article : Google Scholar : PubMed/NCBI
34	Komori J, Marusawa H, Machimoto T, et al: Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology. 47:888–896. 2008. View Article : Google Scholar : PubMed/NCBI
35	Nagata N, Akiyama J, Marusawa H, et al: Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication. J Gastroenterol. 49:427–435. 2014. View Article : Google Scholar : PubMed/NCBI
36	Kang DW, Hwang WC, Park MH, et al: Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells. Oncogene. 32:3531–3542. 2013. View Article : Google Scholar : PubMed/NCBI
37	Sugai T, Habano W, Endoh M, et al: Molecular analysis of gastric differentiated-type intramucosal and submucosal cancers. Int J Cancer. 127:2500–2509. 2010. View Article : Google Scholar : PubMed/NCBI
38	Fritz EL and Papavasiliou FN: Cytidine deaminases: AIDing DNA demethylation? Genes Dev. 24:2107–2114. 2010. View Article : Google Scholar : PubMed/NCBI
39	Tajima Y, Shimoda T, Nakanishi Y, et al: Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: Immunohistochemical analysis of 136 lesions. Oncology. 61:212–220. 2001. View Article : Google Scholar : PubMed/NCBI
40	Tsukashita S, Kushima R, Bamba M, Sugihara H and Hattori T: MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer. 94:166–170. 2001. View Article : Google Scholar : PubMed/NCBI
41	Yuasa H, Inada K, Watanabe H and Tatematsu M: A phenotypic shift from gastric-intestinal to solely intestinal cell types in intestinal metaplasia in rat stomach following treatment with X-rays. J Toxicol Pathol. 15:85–93. 2002. View Article : Google Scholar